Back
Regions Financial Vs. Axsome Therapeutics Industry Stock Comparison
Buy
60
RF
Regions Financial
Last Price:
$21.43
Seasonality Move:
0.72%
Sell
47
AXSM
Axsome Therapeutics
Last Price:
$118.50
Seasonality Move:
19.74%
Buy
60
Regions Financial (RF)
is a Buy
Is Regions Financial a Buy, Sell or Hold?
-
The current Regions Financial [RF] share price is $21.42. The Score for RF is 60, which is 20% above its historic median score of 50, and infers lower risk than normal.
-
RF is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
47
Axsome Therapeutics (AXSM)
is a Sell
Is Axsome Therapeutics a Buy, Sell or Hold?
-
The current Axsome Therapeutics [AXSM] share price is $118.53. The Score for AXSM is 47, which is 6% below its historic median score of 50, and infers higher risk than normal.
-
AXSM is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
RF Stock Price Chart
What is Regions Financial's stock price today?
-
The Regions Financial share price today is $21.42Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RF is experiencing selling pressure, which indicates risk of future bearish movement.
AXSM Stock Price Chart
What is Axsome Therapeutics's stock price today?
-
The Axsome Therapeutics share price today is $118.53The current trend is moderately bearish and AXSM is experiencing selling pressure, which indicates risk of future bearish movement.
RF Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.42 | Sell |
Relative Strength Index (14 RSI): | 37.83 | Sell |
Chaikin Money Flow: | -3178474 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (21.34 - 23.12) | Sell |
Bollinger Bands (100): | (22.61 - 25.81) | Sell |
AXSM Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.62 | Buy |
Relative Strength Index (14 RSI): | 44.34 | Sell |
Chaikin Money Flow: | -342463 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (120.72 - 129.02) | Sell |
Bollinger Bands (100): | (88.92 - 120.8) | Buy |
RF Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 21.93 | Sell |
20-day SMA: | 21.9 | Sell |
50-day SMA: | 23.32 | Sell |
200-day SMA: | 22.95 | Sell |
8-day EMA: | 21.86 | Sell |
20-day EMA: | 22.13 | Sell |
50-day EMA: | 22.93 | Sell |
200-day EMA: | 22.77 | Sell |
AXSM Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 123.49 | Sell |
20-day SMA: | 123.64 | Sell |
50-day SMA: | 117.5 | Buy |
200-day SMA: | 95.28 | Buy |
8-day EMA: | 122.09 | Sell |
20-day EMA: | 122.82 | Sell |
50-day EMA: | 117.2 | Buy |
200-day EMA: | 98.97 | Buy |
Regions Financial Earnings Growth & RF Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.04 per share, a decrease next quarter of $0.02 per share, an increase this year of $0.15 per share, and an increase next year of $0.23 per share.
Axsome Therapeutics Earnings Growth & AXSM Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.59 per share, an increase next quarter of $0.25 per share, an increase this year of $1.54 per share, and an increase next year of $5.14 per share.
Regions Financial Technical Analysis
Mar 17 | Mar 18 | Mar 19 | Mar 20 | Mar 21 | Mar 24 | Mar 25 | Mar 26 | Mar 27 | Mar 28 | |
---|---|---|---|---|---|---|---|---|---|---|
Mar | ||||||||||
17 | 18 | 19 | 20 | 21 | 24 | 25 | 26 | 27 | 28 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Axsome Therapeutics Technical Analysis
Mar 17 | Mar 18 | Mar 19 | Mar 20 | Mar 21 | Mar 24 | Mar 25 | Mar 26 | Mar 27 | Mar 28 | |
---|---|---|---|---|---|---|---|---|---|---|
Mar | ||||||||||
17 | 18 | 19 | 20 | 21 | 24 | 25 | 26 | 27 | 28 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |